Our discovery that TRA16-positive cancer cells and endothelial cells exhibit more active intercellular communication highlights TRA16 as a potential novel target for anti-angiogenesis therapy by disrupting cellular interactions within the tumor microenvironment. This evidence concerns the gene NR2C2AP and cancer.